HR 4605
End Prescription Drug Ads Now Act
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill prohibits drug manufacturers from using direct-to-consumer advertising, such as television, radio, print media, digital platforms, and social media, to promote their prescription drugs. It aims to limit the influence of these advertisements on consumers' decisions about medication. The bill specifically targets drugs approved under the Federal Food, Drug, and Cosmetic Act and licensed under the Public Health Service Act, and it will take effect 30 days after the bill’s passage. This legislation seeks to reduce the potential for misleading or overly promotional advertising of prescription drugs.
Key provisions
- Bans direct-to-consumer advertising of prescription drugs.
- Defines ‘direct-to-consumer advertising’ to include various promotional channels.
- Applies to drugs approved under the Federal Food, Drug, and Cosmetic Act.
- Applies to drugs licensed under the Public Health Service Act.
- The prohibition will take effect 30 days after the bill’s enactment.
- The ban applies regardless of when the drug was approved or licensed.
Who is affected
- Drug Manufacturers
- Prescription Drug Consumers
- Healthcare Providers
- Pharmaceutical Industry
- Advertising Agencies
Notable changes
- Creates a new restriction on pharmaceutical advertising.
- Limits the use of social media for drug promotion.
- Establishes a 30-day timeframe for the ban to take effect.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.
119th CONGRESS — 1st Session
H. R. 4605
IN THE HOUSE OF REPRESENTATIVES
A BILL
To ban drug manufacturers from using direct-to-consumer advertising, including social media, to promote their products.
This Act may be cited as the End Prescription Drug Ads Now Act
.
If it is a drug approved under section 505 or licensed under section 351 of the Public Health Service Act, and subject to section 503(b)(1), and the holder of the approved application under section 505 or of the license under such section 351 has conducted direct-to-consumer advertising of the drug within the most recent 30-day period.
The amendment made by subsection (a) shall take effect 30 days after the date of enactment of this Act, and shall apply with respect to any drug approved under section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355) or licensed under section 351 of the Public Health Service Act (42 U.S.C. 262), regardless of when the drug was approved or licensed.